Clinical Trials

We are evaluating our lead regulatory T cell (Treg) product in clinical trials. This is a critical step in making our hope of finding a cure a reality.

Regulate-RA

We have initiated a Phase 1 study of our lead cell therapy candidate, SBT-77-7101, in patients with rheumatoid arthritis.

For more information Regulate-RA, please visit our clinical trial website.

Learn More

Regulate-HS

We have also initiated a Phase 1 study of 7101 in patients with hidradenitis suppurativa.

For more information about Regulate-HS please visit our clinical trial website.

Learn More